(Press-News.org) Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a test they say will allow them to test thousands of FDA-approved drugs to see if they will work against the bacteria that causes tick-borne Lyme disease.
The researchers, reporting Nov. 3 in the journal PLOS ONE, say doctors and patients are desperate for new treatments for Lyme disease, which in many people is cleared up with a few weeks of antibiotics but, in some, lingers long after completion of the standard drug regimen. Until now, it has been very difficult to determine on a large scale which drugs work against these lingering Borrelia burgdorferi – the bacteria that cause Lyme disease – hampering new drug discovery for the organism.
Study leader Ying Zhang, MD, PhD, a professor in the Bloomberg School's Department of Molecular Microbiology and Immunology, and his colleagues tweaked a test typically used for simply counting DNA in samples in the lab. Using the test, they were able to quantify how many Borrelia burgdorferi are alive and how many are dead after each drug was added to the bacteria. The method stains the living bacteria green and the dead or dying bacteria red in a way that filters out the noise that can corrupt existing tests.
"It's superior to the current gold standard for testing Borrelia viability," Zhang says. "This could become be the new gold standard."
The most exciting part of the development of the test, Zhang says, is that his team has already used it to identify a series of antibiotics approved to treat other infections that show promise in the lab against the lingering Borrelia burgdorferi bacteria, known as persisters. In a study published in July in the journal Emerging Microbes and Infections, Zhang and colleagues used the new test – called the SYBR Green I/PI assay – to identify several antibiotics that showed promise against the persistent bacteria that appear immune to the current Lyme antibiotics. That paper has been the most popular on the journal's website, and patients, doctors and researchers have been contacting Zhang interested in testing out the most promising of the newly identified drugs.
The new test enables researchers to analyze thousands of drugs at a time because its use can directly measure the viability of the bacteria after drug treatment and doesn't require each bacteria sample to be washed, as the currently used LIVE/DEAD BacLight assay does. In skipping that step, the new test is not only more accurate but also more efficient, is less expensive and takes less time, Zhang says.
Lyme disease is named after the town in Connecticut where it was first recognized in 1975. It is found from Maine to Virginia along the East Coast of the United States, peaking in June and July. The tick causes a skin reaction that resembles a bulls-eye or spider bite. If left untreated, Lyme disease may lead to systemic problems such as neurologic and arthritis symptoms weeks or months later. The antibiotic doxycycline or amoxicillin is considered the most effective treatment in resolving early signs of infection and preventing the majority of later symptoms but is ineffective for late-stage disease.
While most people with the disease are fine after a short course of antibiotics, a large subset of patients – some estimates say as high as 20 percent or more – suffer long-term symptoms including fatigue, musculoskeletal pain and memory problems. Their precise diagnosis has long been a controversial topic in medical circles. Some doctors believe that very few people experience persistent Lyme-related symptoms, known as post-treatment Lyme disease syndrome (PTLDS) or chronic Lyme disease. They say that most of the complaints of fatigue, headaches and memory problems in the weeks and months after a Lyme diagnosis, are just the aches and pains of daily life.
Zhang says it is very likely that these symptoms occur because the standard course of antibiotics does not get all of the Borrelia burgdorferi and these lingering bacteria remain in the body despite treatment with current Lyme antibiotics. The problem is that while a blood test may help to confirm Lyme disease, there is no definitive test for PTLDS as no bacteria can be cultured after antibiotic treatment and there are no approved or proven treatments.
The new drugs identified by Zhang's assay appear to specifically target these persisters in the lab. The question remains as to whether they will do the same thing in humans. Some doctors are considering prescribing the drugs off-label for persistent Lyme disease symptoms, even without evidence showing it will work. Zhang cautions that animal studies should be done to see if they work before they are tested in Lyme disease patients, even though these are clinically used drugs for treating other infections, as inappropriate use of antibiotics can have side effects.
"There are a significant number of people who are sick and desperate for a cure for their Lyme disease symptoms months and even years after they have been told they are cured of the disease," Zhang says. "The current drugs we use aren't good enough for these persistent cases. This is why I have been getting so many calls and emails about our test and the drugs we have identified."
INFORMATION:
"An Optimized SYBR Green I/PI Assay for Rapid Viability Assessment and Antibiotic Susceptibility Testing for Borrelia burgdorferi" was written by Jie Feng, Ting Wang, Shuo Zhang, Wanliang Shi and Ying Zhang.
The study was funded by the Lyme Research Alliance and LymeDisease.org.
New test shows promise in identifying new drugs to treat Lyme disease
Demand high for antibiotics to combat Lyme bacteria that lingers, in some, long after completion of standard drug regimen
2014-11-03
ELSE PRESS RELEASES FROM THIS DATE:
PNAS: From HIV to cancer, IL-37 regulates immune system
2014-11-03
A University of Colorado Cancer Center study published in this month's Proceedings of the National Academy of Sciences describes the activity of a recently discovered communication molecule of the body's immune system, Interleukin 37 or IL-37. It has been known to limit inflammation and the current study reports its activity in the adaptive immune system: IL-37 inhibits the ability of the immune system to recognize and target new antigens.
"Knowing this mechanism that underlies IL-37's effect on the immune system now allows us to study IL-37 function and perhaps dysfunction ...
NASA sees Super Typhoon Nuri's eye open in 2 days
2014-11-03
Over the course of two days, from Nov. 1 to Nov. 3, NASA's Aqua satellite watched from space as Tropical cyclone Nuri strengthened into a Super Typhoon and "opened" or developed an eye.
On Nov. 1, when the Moderate Resolution Imaging Spectroradiometer or MODIS instrument aboard NASA's Aqua satellite captured a visible image of Super Typhoon Nuri at 04:30 UTC (12:30 a.m. EDT) and it had not yet developed an eye. On Nov. 3 at 04:20 UTC (12:20 a.m. EDT) MODIS on Aqua passed over Super Typhoon Nuri again after it developed an eye. By Nov. 3 the bands of thunderstorms spiraling ...
String field theory could be the foundation of quantum mechanics
2014-11-03
Two USC researchers have proposed a link between string field theory and quantum mechanics that could open the door to using string field theory — or a broader version of it, called M-theory — as the basis of all physics.
"This could solve the mystery of where quantum mechanics comes from," said Itzhak Bars, USC Dornsife College of Letters, Arts and Sciences professor and lead author of the paper.
Bars collaborated with Dmitry Rychkov, his Ph.D. student at USC. The paper was published online on Oct. 27 by the journal Physics Letters.
Rather than use quantum ...
'Mild' control of systolic blood pressure in older adults is adequate: 150 is good enough
2014-11-03
CORVALLIS, Ore. – A broad review of the use of medications to reduce blood pressure has confirmed that "mild" control of systolic pressure is adequate for adults age 65 or older - in the elderly, there's no clear benefit to more aggressive use of medications to achieve a lower pressure.
Historically, most medical practitioners tried to achieve control of systolic pressure – the higher of the two blood pressure readings – to 140 or less. Recently changed guidelines now suggest that for adults over 60, keeping the systolic pressure at 150 or less is adequate, ...
Inhaled Ebola vaccine may offer long-term protection from virus
2014-11-03
AUSTIN, Texas—A potentially breathable, respiratory vaccine in development has been shown to provide long-term protection for non-human primates against the deadly Ebola virus, as reported this week in the online edition of the journal Molecular Pharmaceutics.
Results from a recent pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long lasting, which could have significant global implications in controlling future outbreaks. A breathable vaccine could surmount the logistical obstacles of storing, ...
New research reveals what to discuss near life's end
2014-11-03
Hamilton, ON (Nov. 3, 2014) – A study led by a McMaster University researcher has identified the top five things health care teams should discuss with hospitalized patients and their families at the end of life, but the research also found gaps between what patients would like and the care they receive.
In the study published today in CMAJ (Canadian Medical Association Journal), seriously ill hospitalized patients and their families say the most important aspects to discuss are:
Preferences for care in the event of life-threatening illness
...
End-of-life discussions: The top 5 things to talk about with patients and their families
2014-11-03
What are the most important things for health care teams to talk about in end-of-life discussions with patients in hospital and their families? A new study published in CMAJ (Canadian Medical Association Journal) asked older patients and their families for their top priorities and found gaps between what patients would like and the care they actually receive.
"Our findings could be used to identify important opportunities to improve end-of-life communication and decision-making in the hospital setting," states Dr. John You, lead author of the study and associate professor ...
Most mental health disorders not increasing in children and youth: Large Canadian study
2014-11-03
Symptoms of mental illness in children and adolescents do not appear to be increasing, according to a large study of Canadian youth published in CMAJ (Canadian Medical Association Journal)
"Popular media tends to perpetuate the idea that the prevalence of mental disorders is increasing," writes Dr. Ian Colman, Canada Research Chair in Mental Health Epidemiology and associate professor at the University of Ottawa, Ottawa, Ontario, with coauthors. "However, research supporting this position has been inconsistent."
Dr. Colman and colleagues sought to better understand ...
NYU study points to perception divide in abortion: Whom we think we know
2014-11-03
Pro-life Americans are less likely to hear about the abortions women they know have had than are pro-choice Americans, a New York University study shows. The findings, which appear in the journal Sociological Science, point to a previously unexplored divide on the abortion issue: differences in perceptions of those we associate with.
"Americans who are opposed to abortion are less likely to hear that their sister, mother, or friend had an abortion than their pro-choice peers," says Sarah K. Cowan, an assistant professor in NYU's Department of Sociology and the study's ...
Thirdhand smoke: Toxic airborne pollutants linger long after the smoke clears
2014-11-03
Ever walked into a hotel room and smelled old cigarette smoke? While the last smoker may have left the room hours or even days ago, the lingering odors—resulting from noxious residue that clings to walls, carpets, furniture, or dust particles—are thanks to thirdhand smoke.
Scientists at the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), who have made important findings on the dangers of thirdhand smoke and how it adsorbs strongly onto indoor surfaces, have published a new study assessing the health effects of thirdhand smoke ...
LAST 30 PRESS RELEASES:
Being physically active, even just a couple of days a week, may be key to better health
High-fat diet promote breast cancer metastasis in animal models
A router for photons
Nurses and AI collaborate to save lives, reduce hospital stays
Multi-resistance in bacteria predicted by AI model
Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection
Sensing sickness
Cost to build multifamily housing in California more than twice as high as in Texas
Program takes aim at drinking, unsafe sex, and sexual assault on college campuses
Inability to pay for healthcare reaches record high in U.S.
Science ‘storytelling’ urgently needed amid climate and biodiversity crisis
KAIST Develops Retinal Therapy to Restore Lost Vision
Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response
Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid
Low LDL cholesterol levels linked to reduced risk of dementia
Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients
Almost one in ten people surveyed report having been harmed by the NHS in the last three years
Enhancing light control with complex frequency excitations
New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients
New insight into factors associated with a common disease among dogs and humans
Illuminating single atoms for sustainable propylene production
New study finds Rocky Mountain snow contamination
Study examines lactation in critically ill patients
UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award
Doubling down on metasurfaces
New Cedars-Sinai study shows how specialized diet can improve gut disorders
Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana
PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation
ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy
How VR technology is changing the game for Alzheimer’s disease
[Press-News.org] New test shows promise in identifying new drugs to treat Lyme diseaseDemand high for antibiotics to combat Lyme bacteria that lingers, in some, long after completion of standard drug regimen